ENGN enGene Therapeutics Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $161.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $149.3K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $788.0K |
| 2024-Q3 | $2.5M | $0 |
| 2024-Q4 | $5.5M | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $10.1K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$8.1M14 buy days
Sold$788.0K3 sell days
Net insider flow+$7.3Mnet buying · 5 years
Latest trade2026-09-22Grossman William
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Buy | Grossman William | Other C-suite | 5,102 | $1.97 | $10.1K | 1 |
| 2024-10-30 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 561,797 | $8.90 | $5.0M | 1 |
| 2024-10-08 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 800 | $6.60 | $5.3K | 1 |
| 2024-10-07 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 11,844 | $6.55 | $77.6K | 1 |
| 2024-10-04 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 5,997 | $6.54 | $39.2K | 1 |
| 2024-10-03 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 5,769 | $6.48 | $37.4K | 1 |
| 2024-10-02 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 10,153 | $6.37 | $64.7K | 1 |
| 2024-10-01 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 35,279 | $6.44 | $227.2K | 1 |
| 2024-09-30 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 341,332 | $6.34 | $2.2M | 1 |
| 2024-09-27 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 41,639 | $5.97 | $248.8K | 2 |
| 2024-09-27 | Buy | Cooper Ronald Harold Wilfred | CEO | 10,000 | $5.70 | $57.0K | 1 |
| 2024-04-22 | Sell | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% owner | 47,854 | $15.00 | $717.8K | 1 |
| 2024-04-19 | Sell | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% owner | 100 | $15.00 | $1.5K | 1 |
| 2024-04-18 | Sell | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% owner | 4,575 | $15.01 | $68.7K | 1 |
| 2023-12-29 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 10,020 | $9.06 | $90.8K | 2 |
| 2023-12-28 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 5,050 | $7.69 | $38.8K | 1 |
| 2023-12-27 | Buy | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | 2,750 | $7.17 | $19.7K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% owner | $8.0M | $0 | 2024-10-30 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% owner | $0 | $788.0K | 2024-04-22 |
| Cooper Ronald Harold Wilfred | CEO | $57.0K | $0 | 2024-09-27 |
| Grossman William | Other C-suite | $10.1K | $0 | 2026-09-22 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.